Loading clinical trials...
Loading clinical trials...
A Randomized, Multicenter, Double-Masked, Placebo-Controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Vancomycin Hydrochloride Ophthalmic Ointment 1.1% in Patients With Moderate to Severe Bacterial Conjunctivitis
Conditions
Interventions
Vancomycin 1.1%
Placebo
Locations
16
United States
Paramount, California, United States
Petaluma, California, United States
Rancho Cordova, California, United States
Deerfield Beach, Florida, United States
Waterloo, Iowa, United States
Newton, Kansas, United States
Start Date
May 1, 2015
Primary Completion Date
May 31, 2018
Completion Date
May 31, 2018
Last Updated
October 23, 2024
NCT00347932
NCT01330355
NCT01238783
Lead Sponsor
Kurobe LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions